Business · 04/04/2017Updated: 10/17/2026 · 1 min read
US Patent Office Announces Regulatory Review Period for Lawsonia Intracellularis Bacterin Vaccine
Summary
The US Patent and Trademark Office has determined the regulatory review period for the Lawsonia Intracellularis Bacterin Vaccine, following a submission by the manufacturer to extend a patent for the veterinary biologic.
Original source language: Federal Register — Agriculture DepartmentOpen original release →